Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
and acts as a hepatoprotective agent
with Kis of 12 nM and 197 nM for adenosine A2A receptor and adenosine A1 receptor
Asciminib is undergoing clinical development testing in patients with CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia
with marked increase in the release of prostacyclin
All Clostridium perfringens strains had GSK2251052 MICs of >32 μg/ml
trans-Trimethoxyresveratrol 9596 and acts as a hepatoprotectiveTrans Trimethoxyresveratrol is a derivative of Resveratrol (RSV),and it may be a more potent anti inflammatory, antiangiogenic and vascular disrupting agent when compared with resveratrol. In vitro: The in vitro study of resveratrol and trans Trimethoxyresveratrol showed rather weak cytotoxic effects on three cancer cell lines (HepG2, MCF 7, and MDA MB 231), which contradicted a previous study reporting that resveratrol inhibited MCF 7 cells with an